TG Therapeutics, Inc.
BioTech/Drugs - New York, NY, US
TG Therapeutics, Inc. Employees
TG Therapeutics, Inc. Senior Management
TG Therapeutics, Inc. Details
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
Website:
http://www.tgtherapeutics.com/
Employees:
380
HQ:
(212) 554-4484
Location:
New York, NY, US
Revenue:
$23 million
TG Therapeutics, Inc. Technologies
Email Providers
Outlook
Customer Relationship Management
Salesforce
Domain Name Services
Cloudflare DNS
Hosting
CloudFlare Hosting
Other
Mobile Friendly